Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Richard McDonough, MD

Richard McDonough, MD

Fort Myers, Fla., May 25, 2022 – Florida Cancer Specialists & Research Institute, LLS (FCS) welcomes Board-certified medical oncologist Richard McDonough, MD to the statewide practice as of June 1, 2022. He is providing care to patients at the FCS Zephyrhills clinic at 7315 Green Slope Drive, Zephyrhills, Florida 33541.

Dr. McDonough earned his medical degree from the University of Miami, where he also completed his residency training in Internal Medicine at Jackson Memorial Hospital. He completed a fellowship in Hematology/Oncology at the Mayo Clinic in Jacksonville, Florida.

A leader in advocating on behalf of cancer patients to ensure convenient access to high-quality, affordable care, Dr. McDonough served as President of the Florida Society of Clinical Oncology (FLASCO) from 2017 to 2019 and as Treasurer from 2014 to 2017. He currently serves as a committee member of the Community Oncology Alliance and is in frequent contact with members of the U.S. Congress, government agencies and other entities bringing awareness to public policy issues faced by cancer patients and community oncology providers.

“Dr. McDonough is well-known throughout Pasco County for his exceptional skill and compassion, and we are very pleased to welcome him to our practice,” said FCS Chief Executive Officer Nathan H. Walcker.

FCS President & Managing Physician Michael Diaz, MD said, “Dr. McDonough is a respected colleague and I applaud his deep commitment to ensuring that patients have access to a comprehensive range of personalized cancer close to home.”

Learn more about Dr. McDonough here: https://FLCancer.com/RMcDonough

###

About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.

*Prior to approval

For More Information, Contact:
Michelle Robey, VP of Marketing
Michelle.Robey@FLCancer.com
(813) 767-9398

Jennifer Bradley, Director of Corporate Communications
Jennifer.Bradley@FLCancer.com
(847) 280-1740